US multicenter outcomes of endoscopic ultrasound-guided gallbladder drainage with lumen-apposing metal stents for acute cholecystitis

Yakira David, Gaurav Kakked, Bradley Confer, Ruchit Shah, Harshit Khara, David L. Diehl, Matthew RichardKrafft Krafft, Sardar M. Shah-Khan, John Y. Nasr, Petros Benias, Arvinde Trindad, Thiruvengada Muniraj, Harry Aslanian, Prabhleen Chahal, John Rodriguez, Douglas G. Adler, Jason Dubroff, Rabi De Latour, Demetrios Tzimas, Lauren KhannaGregory Haber, Adam J. Goodman, Nicholas Hoerter, Nishi Pandey, Mena Bakhit, Thomas E. Kowalski, David Loren, Austin Chiang, Alexander Schlachterman, Jose Nieto, Ameya Deshmukh, Yervant Ichkhanian, Mouen A. Khashab, Maan El Halabi, Richard S. Kwon, Anoop Prabhu, Ariosto Hernandez-Lara, Andrew Storm, Tyler M. Berzin, John Ponero, Amrita Sethi, Tamas A. Gonda, Vladimir Kushnir, Natalie Cosgrove, Daniel Mullady, Abdullah Al-Shahrani, Lionel D'Souza, Jonathan Buscaglia, Juan Carlos Bucobo, Vineet Rolston, Prashant Kedia, Franklin Kasmin, Satish Nagula, Nikhil A. Kumta, Christopher DiMaio

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND AND STUDY AIMS: EUS-guided gallbladder drainage (EUS-GBD) using lumen apposing metal stents (LAMS) has excellent technical and short-term clinical success for acute cholecystitis (AC). The goals of this study were to determine the long-term clinical outcomes and adverse events (AEs) of EUS-GBD with LAMS.

PATIENTS AND METHODS: A multicenter, retrospective study was conducted at 18 US tertiary care institutions. Inclusion criteria: any AC patient with attempted EUS-GBD with LAMS and minimum 30-day post-procedure follow-up. Long-term clinical success was defined as absence of recurrent acute cholecystitis (RAC) > 30 days and long-term AE was defined as occurring > 30 days from the index procedure.

RESULTS: A total of 109 patients were included. Technical success was achieved in 108 of 109 (99.1%) and initial clinical success in 106 of 109 (97.2%). Long-term clinical success was achieved in 98 of 109 (89.9%) over a median follow-up of 140 days (range 30-1188). On multivariable analysis (MVA), acalculous cholecystitis (odds ratio [OR] 15.93, 95% confidence interval [CI] 1.22-208.52, P = 0.04) and the occurrence of a LAMS-specific AE (OR 63.60, 95% CI 5.08-799.29, P <0.01) were associated with RAC. AEs occurred in 38 of 109 patients (34.9%) at any time, and in 10 of 109 (9.17%) > 30 days from the index procedure. Most long-term AEs (7 of 109; 6.42%) were LAMS-specific. No technical or clinical factors were associated with occurrence of AEs. LAMS were removed in 24 of 109 patients (22%). There was no difference in RAC or AEs whether LAMS was removed or not.

CONCLUSIONS: EUS-GBD with LAMS has a high rate of long-term clinical success and modest AE rates in patients with AC and is a reasonable destination therapy for high-risk surgical candidates.

Original languageEnglish
Article numbera24955542
Pages (from-to)a24955542
Number of pages10
JournalEndoscopy International Open
Volume13
DOIs
StatePublished - Jan 13 2025

Keywords

  • Biliary tract
  • Endoscopic ultrasonography
  • Intervention EUS
  • Performance and complications
  • Quality and logistical aspects

Fingerprint

Dive into the research topics of 'US multicenter outcomes of endoscopic ultrasound-guided gallbladder drainage with lumen-apposing metal stents for acute cholecystitis'. Together they form a unique fingerprint.

Cite this